0001567619-23-006698.txt : 20230727 0001567619-23-006698.hdr.sgml : 20230727 20230727113255 ACCESSION NUMBER: 0001567619-23-006698 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230727 DATE AS OF CHANGE: 20230727 EFFECTIVENESS DATE: 20230727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 2A Biosciences, Inc. CENTRAL INDEX KEY: 0001968754 IRS NUMBER: 920657960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-475787 FILM NUMBER: 231116182 BUSINESS ADDRESS: STREET 1: 1714 BRYN MAWR CITY: SANTA MONICA STATE: CA ZIP: 90405 BUSINESS PHONE: (917) 757-1051 MAIL ADDRESS: STREET 1: 1714 BRYN MAWR CITY: SANTA MONICA STATE: CA ZIP: 90405 D/A 1 primary_doc.xml X0708 D/A LIVE 0001968754 2A Biosciences, Inc. 2A Biosciences, Inc. 1714 BRYN MAWR SANTA MONICA CA CALIFORNIA 90405 (917) 757-1051 DELAWARE None None Corporation true 2022 Alexander Speiser 2A Biosciences, Inc. 1714 Bryn Mawr Santa Monica CA CALIFORNIA 90405 Executive Officer Director Chief Executive Officer Charles David Nichols 2A Biosciences, Inc. 1714 Bryn Mawr Santa Monica CA CALIFORNIA 90405 Executive Officer Director Chief Scientific Officer David Earl Nichols 2A Biosciences, Inc. 1714 Bryn Mawr Santa Monica CA CALIFORNIA 90405 Executive Officer Director Chief Drug Discovery Officer Timothy Paul Foster 2A Biosciences, Inc. 1714 Bryn Mawr Santa Monica CA CALIFORNIA 90405 Director Executive Officer Head of Research Gopal Das Eternal Therapeutics, Inc. Suite 150 San Diego CA CALIFORNIA 92121 Director Pharmaceuticals Decline to Disclose 06b true 0001567619-23-005028 2023-03-01 false true true true SAFE (Simple Agreement for Future Equity) securities, including underlying securities upon conversion of SAFEs false 0 5500000 3779777 1720223 Target maximum raise false 13 0 0 0 false 2A Biosciences, Inc. /s/ Alexander Speiser Alexander Speiser Chief Executive Officer 2023-07-26